Clinical trial
Biomarkers of ADHD Treatment Response
NCT05650775 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarkers of ADHD Treatment Response
- Lead sponsor
- Boston Children's Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 17, 2023
- Completion date
- March 30, 2024
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adhd